The purpose and intent of this retrospective performance assessment was to review the history of developmental neurotoxicity (DNT) testing. This review demonstrates the extensive scientific efforts, including basic neurotoxicology research, interlaboratory collaborative studies, expert workshops, and validation studies, that form the foundation for this testing paradigm. We also review the relevance, applicability, and use of the DNT study in human health risk assessment and the historical performance of the DNT study. This analysis was developed by an OECD expert group \[[@b96-ehp-117-17]\] in support of drafting the OECD DNT Test Guideline 426 (TG 426; [@b95-ehp-117-17]) that satisfies current OECD validation criteria.

OECD validation criteria are described in Guidance Document 34 (GD34; [@b93-ehp-117-17]), which addresses the validation and regulatory acceptance of new or updated test methods for hazard characterization. They are based on the "Solna Principles" for validation and regulatory acceptance ([@b89-ehp-117-17]), but additionally emphasize the importance of flexibility and adaptability in the validation process without compromising scientific rigor.

GD34 ([@b93-ehp-117-17]) also provides concise definitions of related concepts such as accuracy, concordance, performance standards, predictivity, relevance, reliability, repeatability, reproducibility, sensitivity, and specificity. The terminology and definitions presented in GD34 (Annex 1) were used in the DNT review process; however, individual studies may have varied slightly in the definition of terms.

The first DNT guideline was developed by the U.S. Environmental Protection Agency (EPA) and has been subjected to numerous validation studies and rigorous peer reviews over the years. The U.S. EPA has deemed the method validated for its regulatory purposes. As described herein, extensive supportive materials for the relevance, reliability, and overall performance of the DNT study are available. Until recently, only the U.S. EPA DNT guideline has been available for testing laboratories. The new OECD TG 426 ([@b95-ehp-117-17]) DNT guideline will fill a regulatory gap for OECD member countries. This review summarizes the considerable work that has been performed in the development of the DNT study and provides the rationale for the regulatory acceptance of TG 426 as a new OECD test guideline.

The U.S. EPA DNT guideline ([@b136-ehp-117-17]), the prototype for TG 426, was founded upon an extensive scientific database. This includes interlaboratory validation studies, such as the Collaborative Behavioral Teratology Study (CBTS), which was conducted in the mid-1980s. A separate group of experts at the Williamsburg Workshop ([@b55-ehp-117-17]) agreed that the methods in the DNT study are sensitive to known human developmental neurotoxicants. An expert consultation meeting conducted in 2000 ([@b92-ehp-117-17]) discussed issues on validation, especially of individual test components versus the whole DNT test method. In doing so, they reviewed the extensive history of international validation, peer review, and evaluation of DNT methods contained in the public record. Experts agreed that individual assays of the DNT test method have been shown to be relevant, reliable, and sensitive and that extensive information demonstrates the validity of individual components of the DNT test method ([@b92-ehp-117-17]).

The field of developmental neurotoxicology evolved from the disciplines of neurotoxicology, experimental and development psychology, and developmental toxicology, through an extensive history of scientific research and regulatory consideration. Developmental toxicity is defined in GD43 ([@b97-ehp-117-17]), which states that effects may result from either prenatal or postnatal exposure, may manifest at any life stage, and may be expressed as functional deficits.

The DNT study is a specialized type of developmental toxicity study designed to screen for adverse effects of pre- and postnatal exposure on the development and function of the nervous system and to provide dose--response characterizations of those outcomes. The U.S. EPA and OECD DNT guidelines recommend administration of the test substance during gestation and lactation. Cohorts of offspring (typically rat) are randomly selected from control and treated litters for evaluations of gross neurologic and behavioral abnormalities during postnatal development and adulthood ([@b95-ehp-117-17]; [@b136-ehp-117-17]). These include assessments of physical development, behavioral ontogeny, motor activity, motor and sensory function, learning and memory, and postmortem evaluation of brain weights and neuropathology.

History of DNT Test Guideline Development
=========================================

The evolution of DNT studies has its roots in scientific publications that began to appear in the early 1960s; the science has continued to develop over the past four decades. An extensive scientific literature, composed of studies evaluating the potential for physical, pharmaceutical, and environmental agents to affect the development and function of the nervous system after prenatal and early post-natal exposure, provides a strong foundation for guideline development, implementation, and validation. [Table 1](#t1-ehp-117-17){ref-type="table"} lists some of the key contributions to the development of the DNT guidelines. [Table 2](#t2-ehp-117-17){ref-type="table"} briefly summarizes the history of U.S. EPA and OECD DNT guideline development. Although prenatal developmental toxicity test guidelines have existed for some time (e.g., [@b86-ehp-117-17]), the first regulatory protocol designed to evaluate DNT was developed and implemented by the U.S. EPA in support of hazard evaluation for specific solvents ([@b133-ehp-117-17]), and a DNT guideline applicable to the evaluation of both toxic substances and pesticides was finalized in 1991 ([@b134-ehp-117-17]). In 1998, it was revised ([@b136-ehp-117-17]) as part of a broader U.S. effort to harmonize testing guidelines within U.S. EPA program offices and with the OECD.

In 1995, the OECD initiated the development of the DNT TG 426 ([@b87-ehp-117-17]). The first draft of TG 426 was prepared after an expert consultation meeting ([@b88-ehp-117-17]), using the U.S. EPA DNT guideline as the design template, and addressed a number of important issues and recommended improvements. The draft TG 426 was distributed for comment in 1998, and significant technical issues identified by this review (e.g., the optimal duration of treatment, direct dosing of preweaning rodents, and conduct of morphometric evaluations) were further discussed at an expert consultation meeting in 2000 ([@b92-ehp-117-17]). A revised draft was subsequently circulated for review, and comments from OECD member countries were addressed at a 2005 expert consultation meeting ([@b94-ehp-117-17]). The final version of TG 426 was adopted by the OECD Council in 2007 ([@b95-ehp-117-17]).

In the context of toxicologic screening and testing to support human health risk assessment and chemical regulatory activities, the DNT study fills an information requirement that is not satisfied by other OECD test guidelines. Notably, it is the only test guideline that includes functional, behavioral, and anatomical evaluations of the nervous system at multiple time points, in test subjects that were exposed to test substance during critical pre- and early postnatal periods of nervous system development. This test method has been used extensively in the past two decades on a wide variety of chemicals ([Table 3](#t3-ehp-117-17){ref-type="table"}).

Scientific Basis of DNT Guideline
=================================

The test methods recommended in the DNT guideline have been extensively reviewed and evaluated over the last 25 years. This has included the conduct of a number of meetings and collaborative studies involving experts from academic, industry, regulatory, and public interest groups. Pivotal influences and key events in the history of the development of the DNT guideline ([Table 2](#t2-ehp-117-17){ref-type="table"}) include both research on test methods development and efforts to characterize and document the sensitivity, reliability, and performance of the test methods, including a number of intralaboratory collaborative efforts. In the 1970s, a series of studies were conducted in which rats were developmentally exposed to a variety of xenobiotics and subsequently tested during postnatal development using a battery of neurobehavioral tests ([@b16-ehp-117-17]; [@b146-ehp-117-17]). Other laboratories used behavioral and histologic batteries, focusing on sensory and motor function, in adult rodents exposed to a wide variety of neurotoxicants ([@b100-ehp-117-17]; [@b129-ehp-117-17]). A large body of research has provided an immense database on the ability of the functional observational battery to detect and characterize the effects of drugs and environmental chemicals in adult and developing animal models ([@b42-ehp-117-17]; [@b50-ehp-117-17]; [@b74-ehp-117-17]). This early work was followed by wide-ranging efforts to characterize the specificity of these test methods and the impact of both organismal and experimental factors (e.g., noise, species, strain, gender, test history) ([@b44-ehp-117-17]; [@b59-ehp-117-17]; [@b61-ehp-117-17]; [@b117-ehp-117-17]). Ultimately, the result of more than 30 years of work in this area is a consensus opinion of neuro toxicologists that proper use and interpretation of the data derived from these test methods provide unique insight into the impact of xenobiotics on the developing and adult nervous system \[[@b25-ehp-117-17]; [@b49-ehp-117-17]; [@b131-ehp-117-17]\].

The development of test methods in neurotoxicology also includes a long history of efforts to characterize the interlaboratory reliability and sensitivity of the test methods now included in the DNT study design. An article comparing a learning and retention method among three laboratories ([@b14-ehp-117-17]) was followed by the CBTS ([@b11-ehp-117-17]; [@b53-ehp-117-17]) and the "Williamsburg Workshop" on qualitative and quantitative comparability of human and animal DNT ([@b55-ehp-117-17]). These efforts addressed various aspects of DNT study design and conduct, providing a sound scientific basis for the test method and its use in hazard evaluation. Since the publication of the U.S. EPA DNT guideline ([@b134-ehp-117-17]), a continued scientific effort has reviewed and updated methodologies, for neurotoxicology in general and for developmental neurotoxicology in particular. Examples of such reviews include the IPCS collaborative study on neurobehavioral screening methodologies ([@b62-ehp-117-17]), an International Life Sciences Institute (ILSI) Risk Science Institute (RSI) workshop on Developmental Neurotoxicity and Risk Assessment ([@b67-ehp-117-17]), a collaborative study on neurobehavioral screening in 11 Japanese laboratories ([@b99-ehp-117-17]), and a Behavioral Test Methods Workshop ([@b115-ehp-117-17]). Descriptions of each of these efforts and their contributions to the scientific basis for DNT testing follow.

The CBTS
--------

Several of the test procedures developed in early behavioral teratology studies underwent validation in a large interlaboratory effort, the CBTS. This project characterized the performance of a standardized neurodevelopmental test battery in six different laboratories after *in utero* and lactational exposure to two known neurotoxicants, methylmercury and amphetamine. The study examined the intra- and inter-laboratory reliability and sensitivity of several behavioral test methods and the effects of a number of other litter- and gender-related variables. The peer-reviewed publications that resulted from the CBTS included descriptions of the background and overview ([@b53-ehp-117-17]), protocol and test procedures ([@b3-ehp-117-17]), data entry and test systems ([@b4-ehp-117-17]), preliminary research ([@b2-ehp-117-17]), statistical approach ([@b78-ehp-117-17]), results ([@b11-ehp-117-17]), and implications, current applications, and future directions ([@b54-ehp-117-17]). Additionally, the results of a workshop held to review the CBTS data were published ([@b15-ehp-117-17]; [@b45-ehp-117-17]; [@b56-ehp-117-17]; [@b116-ehp-117-17]; [@b130-ehp-117-17]). In a corollary study, many end points in the CBTS study were compared within one laboratory to an additional set of behavioral end points, named the Cincinnati Test protocol, using both methylmercury and -amphetamine ([@b142-ehp-117-17], [@b143-ehp-117-17]). The conclusion was that the effects of methylmercury were detected by both the CBTS end points and some of the additional end points in the Cincinnati Test protocol ([@b144-ehp-117-17]). The CBTS showed that replicability of data among laboratories using a standardized protocol was excellent and that both positive effects (e.g., with methyl-mercury exposure) and the lack of effects (e.g., after low-level amphetamine exposure) were replicable. The CBTS also demonstrated that the DNT test procedures were sufficiently sensitive; no more than a 5--20% change from control values was required to detect an effect.

The European Interlaboratory Collaborative Study
------------------------------------------------

In the 1980s, the European Interlaboratory Study Group on Behavioural Teratology conducted a study of behavioral test methods ([@b6-ehp-117-17]; [@b34-ehp-117-17]; [@b36-ehp-117-17]; [@b112-ehp-117-17]; [@b121-ehp-117-17]). Three laboratories, one each from industry, academia, and government, tested animals perinatally exposed to methylmercury. The results indicated that behavioral tests were more sensitive than reproductive end points and that automated procedures and measures aimed at specific functional capacities were more sensitive than nonspecific behavioral measures ([@b36-ehp-117-17], [@b35-ehp-117-17]).

The Williamsburg Workshop
-------------------------

In 1989, the U.S. EPA held a workshop on the Qualitative and Quantitative Comparability of Human and Animal Developmental Neurotoxicity (also known as the "Williamsburg Workshop") to provide scientific input into DNT protocol design and to evaluate its appropriateness for use in risk assessment ([@b55-ehp-117-17]). Expert scientists from government, industry, public interest groups, and academia reviewed a range of representative chemicals and environmental exposures, including drugs (cannabis, cocaine, methadone, and phencyclidine) ([@b48-ehp-117-17]), ethanol ([@b33-ehp-117-17]), the anticonvulsant phenytoin ([@b5-ehp-117-17]), and environmental contaminants such as methylmercury ([@b13-ehp-117-17]), lead ([@b30-ehp-117-17]), polychlorinated biphenyls ([@b127-ehp-117-17]), and ionizing radiation ([@b113-ehp-117-17]). Based on data available for these known human developmental neurotoxicants, the workshop participants concluded that DNT methodologies were adequate for detecting DNT. A number of specific issues directly relevant to design and usefulness of DNT studies were extensively evaluated by participants ([@b12-ehp-117-17]; [@b59-ehp-117-17]; [@b119-ehp-117-17]; [@b132-ehp-117-17]). Additionally, workshop participants addressed the relationship between biologic end points specified by DNT guidelines and adverse findings observed in humans after exposure to the developmental neurotoxic agents under consideration. A major conclusion of the workshop was that the DNT protocol would have identified each of the agents presented at the workshop as a potential developmental neurotoxicant ([@b40-ehp-117-17]), although the critical effects and the dose at which the effects were observed could vary across species. The workshop participants also concluded that the laboratory animal is an adequate surrogate for humans because many of the biologic and behavioral mechanisms underlying these neurologic functions are shared between humans and laboratory animals. The predictive power of DNT guideline studies was attributed largely to the scope of neurobehavioral and neuropathologic tests used that can evaluate neurologic functions across multiple domains (i.e., sensory, motivational/arousal, cognitive, and motor).

Collaborative studies of the Japanese Teratology Society
--------------------------------------------------------

The Japanese Teratology Society established the Behavioral Teratology Meeting as a satellite meeting of the Japanese Teratology Society in 1982. This group sponsored a number of collaborative studies conducted primarily by pharmaceutical industry, and contract laboratories ([@b124-ehp-117-17]). The first effort involved 21 institutions that investigated the effects of parametric variables (water temperature, number of trials) on performance in a water T-maze and two-way shuttle box ([@b68-ehp-117-17]). This was followed by a larger study involving 46 laboratories that investigated the effects of six chemicals (chlorpromazine, ethanol, hydroxyurea, methylazoxymethanol, phenylalanine, and vitamin A) ([@b69-ehp-117-17]). These studies demonstrated that the T-maze test was reliable, but possibly not as sensitive as needed, and suggested the need for more complicated learning paradigms for this method ([@b125-ehp-117-17]). Workshops were then held between 1988 and 1990, with three subgroups: reflexes and sensory function, activity and emotionality, and learning ([@b126-ehp-117-17]). Subsequently, a core battery test draft for behavioral developmental toxicity was proposed. Its utility was examined with three posi tive behavioral teratogens during 1993--1997: phenytoin ([@b41-ehp-117-17]; [@b123-ehp-117-17]), retinoic acid ([@b79-ehp-117-17]), and nicotine ([@b122-ehp-117-17]). The numbers of participating laboratories were 32, 28, and 18, respectively. It was concluded that the proposed core battery of tests is useful as a method to detect postnatal developmental disorders, including behavioral dysfunction, in rats.

The IPCS Study
--------------

The IPCS collaborative study was an interlaboratory evaluation of neurobehavioral screening methodologies used in adult and DNT studies ([@b62-ehp-117-17]; [@b75-ehp-117-17]). A total of eight laboratories participated in proficiency studies ([@b70-ehp-117-17]), and the full study evaluated seven neurotoxic positive control chemicals \[triethyl tin, acrylamide, parathion, *p*,*p*′-dichlorodiphenyltrichloroethane (DDT), toluene, *N*,*N*′-methylene bisacrylamide, and lead acetate\] in adult male rats ([@b71-ehp-117-17], [@b72-ehp-117-17]). The study examined variability associated with the test methods and reasons for differences. The overall conclusion of this extensive study was general "agreement across laboratories in terms of their ability to detect dose-related changes in behavioral end points with prototypic neurotoxic agents" ([@b17-ehp-117-17]). The study results were also reviewed at a workshop held in 1995 in Capri, Italy ([@b128-ehp-117-17]) and were presented in a symposium at the 1996 meeting of the Society of Toxicology ([@b73-ehp-117-17]).

ILSI workshop on DNT testing
----------------------------

In 1999, ILSI established a working group of scientists from government, industry, academia, and nonprofit nongovernmental organizations ([@b67-ehp-117-17]) that was charged with evaluating revisions to the published U.S. EPA DNT guideline that were also included in the draft OECD TG 426. Some of these changes were implemented by the U.S. EPA Office of Pesticide Programs (OPP) when it issued Data Call-In notices for organophosphate pesticides with tolerances ([@b138-ehp-117-17]). The revisions included extension of the offspring dosing period through to the age of weaning, ensuring that the pups are exposed to the test substance, increasing the number of offspring evaluated neuropathologically, and collecting chemical-class--specific biomarker data. The extension of the dosing period during the lactation period raised several issues, specifically in the areas of pharmacokinetic/toxicokinetic data needs, behavioral testing, and neuropathologic evaluation. Overall, the working group agreed that the current DNT test protocol was based upon solid scientific principles and experience, that there were opportunities to revise and improve some aspects of the U.S. EPA guideline study, and that further research would be valuable in providing the scientific basis for development of TG 426 ([@b25-ehp-117-17]; [@b32-ehp-117-17]; [@b43-ehp-117-17]; [@b92-ehp-117-17]). Further considerations of methodologic issues related to the conduct of the DNT study include an ILSI workshop on the direct dosing of preweaning mammals. This workshop culminated in a monograph on direct dosing that has broad application to study design for many areas of research, for example, pharmaceuticals, environmental pollutants, and academic research ([@b76-ehp-117-17]; [@b149-ehp-117-17]).

The Japanese Interlaboratory Study
----------------------------------

An interlaboratory evaluation of neurobehavioral screening methodologies (used in DNT studies as well as adult neurotoxicity studies) was carried out by 11 safety research laboratories in Japan ([@b99-ehp-117-17]). The study examined technical problems in evaluating the neurotoxic potential of chemicals, conducting a variety of neurobehavioral tests on rats after either acute or repeated (28-day) exposure to acrylamide or 3,3′-iminodiproprionitrile. All laboratories detected neurotoxicity of both chemicals. The report identified interlaboratory differences in test method sensitivity and concluded that it is important to standardize the methods and criteria and to improve observers' skills ([@b99-ehp-117-17]).

The Behavioral Test Methods Workshop
------------------------------------

In 2003, a workshop was conducted to discuss experimental procedures and practices that could help enhance the utility of behavioral data as a reliable index of neurotoxicity and in the safety evaluation of chemical substances ([@b115-ehp-117-17]). Workshop participants included individuals from all sectors of the neuroscience community: academia, government, testing laboratories, industry, and nonprofit nongovernmental organizations. Overall conclusions from the workshop were that consensus can be reached on the fundamentals of behavioral assessment and that aspects such as experimental design, test method selection, training of technical staff, validation, control of confounding factors, data variability, data analysis, and data interpretation should be carefully considered in the planning and conduct of behavioral safety assessment ([@b115-ehp-117-17]).

In summary, the scientific basis of the DNT test method has been subjected to an extensive history of international validation, peer review, and evaluation that is contained in the public record. Through the various collaborative efforts and workshops that have been conducted, a number of important conclusions have been drawn. The individual test methods used in the DNT study have been found to be highly relevant for characterizing health risks of neurotoxic chemicals and to be based on solid scientific principles and experience. Using exposures to known human developmental neurotoxicants, the DNT study has been shown to adequately identify the potential for adverse effects of chemical exposure on neurologic development. The intra- and interlaboratory reproducibility, reliability, and sensitivity of the DNT test method has been established, using a variety of test substances.

Use of the DNT Study in Risk Assessment
=======================================

There is a regulatory need for DNT testing to support risk assessments in OECD member countries. Many pesticides and other chemicals are known to affect the adult nervous system, and there are concerns regarding the potential for DNT after early-life exposures to these substances \[[@b84-ehp-117-17]\]. This is particularly important because unique behaviors and activities of children place them at greater risk for increased exposure to xenobiotics by multiple routes ([@b10-ehp-117-17]; [@b147-ehp-117-17]). The call for a more rigorous assessment of the potential for DNT has been issued by scientists from multiple and diverse sectors with an interest in public health protection.

An examination of the historical and potential uses of the DNT study in risk assessment is critical to an overall evaluation of its value in protecting human health. Currently, the largest collection of DNT guideline studies resides with the U.S. EPA OPP, which has obtained information on DNT for specific pesticides to satisfy regulatory mandates ([@b39-ehp-117-17]). The U.S. EPA has furthermore engaged in an ongoing scientific analysis and discourse regarding the conduct of DNT studies, the interpretation of the data from these studies, and their regulatory impact.

A review of 12 DNT studies ([@b63-ehp-117-17]) evaluated by the U.S. EPA Office of Prevention, Pesticides, and Toxic Substances (OPPTS) in support of the registration and/or use of nine pesticides and three solvents was presented to a Scientific Advisory Panel in 1998 ([@b137-ehp-117-17]). For the nine pesticides examined, the analyses demonstrated that the DNT study includes sensitive end points that are not examined in any other test guideline, including prenatal developmental, reproduction, and neurotoxicity studies ([@b86-ehp-117-17], [@b90-ehp-117-17], [@b91-ehp-117-17]), thereby enhancing detection of neurobehavioral and neuropathologic effects in offspring after exposure during sensitive periods of neurologic development. As a result, the DNT study, when present in a chemical database, is often identified as a sensitive study and an important source of quantitative and qualitative information for risk assessment.

DNT data have been shown to be valuable in the selection of end points and doses for risk assessment ([@b63-ehp-117-17]; [@b111-ehp-117-17]). As might be expected of a study that uses short-term exposures (\~ 25--40 days) during development, where a single exposure during a critical period may result in developmental insult ([@b107-ehp-117-17]; [@b108-ehp-117-17], [@b109-ehp-117-17], [@b110-ehp-117-17]), the predominant use of the DNT study in pesticide risk assessment has been for acute (single dose) reference doses (RfDs) and for short-term (1--30 days) and intermediate-term (1--6 months) nonoccupational exposures, which are especially applicable to risk assessments for children. Results from DNT studies have also been used in calculating a chronic RfD for lifetime exposure to a toxicant when it has been shown to be the most sensitive study in the toxicology database.

A survey of the use and value of neurobehavioral assessment in safety evaluation was also conducted by [@b66-ehp-117-17]. This survey included the results of multinational studies conducted since 1990 on 174 compounds, including pharmaceutical (81%), agricultural (7%), industrial (1%), or undefined (10%) substances. Notably, the neurobehavioral screening conducted for pharmaceuticals is generally composed of developmental and behavioral assessments of second-generation (F~1~) offspring but does not address all of the end points assessed in a guideline DNT study. Nevertheless, this review found that F~1~ behavioral parameters along with other parameters defined the chronic no observed effect level (NOEL) in 17 of 113 (15%) and solely defined the NOEL in 3 of 113 (2.6%) of the studies examined. The conclusion was that F~1~ behavioral parameters sometimes improved on the standard toxicologic measures of hazard identification, providing information on outcomes not addressed by other standard measures of toxicity.

By early 2006, a review of regulatory and published sources revealed that approximately 114 DNT studies had been completed using either the U.S. EPA guideline or the draft OECD guideline ([Table 4](#t4-ehp-117-17){ref-type="table"}). The list of agents in [Table 4](#t4-ehp-117-17){ref-type="table"} demonstrates the extensive history and experience regarding the conduct and interpretation of DNT studies. The outcomes of these efforts do not comprise a focused attempt to validate the study protocol or specific end points. In fact, a few of these studies did not include all the end points recommended by U.S. EPA or OECD guidelines.

As of August 2006, approximately 75 DNT studies had been submitted to the U.S. EPA OPP in support of pesticide registration. A preliminary survey of the use of DNT studies in risk assessment in OPP was conducted in March 2007 ([@b111-ehp-117-17]). For 58 of the 75 pesticide chemicals, a DNT study had been considered in the weight-of-evidence review of the toxicology database. The DNT study was used to select end points and doses for risk assessments for eight of those chemicals. Importantly, for four of the eight DNT studies, the critical effects either included or were solely based upon off-spring behavioral and neuropathologic parameters that are not evaluated in other guideline studies (i.e., motor activity, auditory startle habituation, learning and memory, and morphometric analysis). This is consistent with the conclusions of the earlier retrospective analysis ([@b63-ehp-117-17]) and provides further evidence of the sensitivity of the DNT study in identifying adverse effects in the young and the important role of DNT studies in human health risk assessments.

In addition to using DNT data for regulatory decisions, some regulatory agencies have also, on a case-by-case basis, incorporated an additional database uncertainty factor into their regulatory decisions because of the absence of DNT data. This approach reflects regulator views that DNT data are valuable in refining permissible exposure levels and that the absence of these data can increase the uncertainty about the toxicity of the chemicals ([@b139-ehp-117-17], [@b140-ehp-117-17]).

Recent reviews have examined specific end points across multiple guideline DNT studies, to demonstrate the value of current methods in hazard characterization and explore further opportunities for methodologic refinement. U.S. EPA scientists have conducted cross-laboratory comparisons of methodologies and results from DNT studies submitted to OPP ([@b27-ehp-117-17], [@b28-ehp-117-17]; [@b65-ehp-117-17], [@b64-ehp-117-17]; [@b106-ehp-117-17], [@b103-ehp-117-17], [@b105-ehp-117-17], [@b104-ehp-117-17]; [@b114-ehp-117-17]). [@b51-ehp-117-17] reviewed the neuropathologic assessments in DNT studies, summarized practical aspects in planning neuropathologic assessments, and highlighted the value of morphology data in reference to both the concurrent behavioral assessments and use in assessing risk. A multisector ILSI RSI workshop examined the evaluation and interpretation of neurodevelopmental end points for human health risk assessment and addressed public health considerations, data interpretation, data variability, positive control data, and statistical analysis ([@b26-ehp-117-17]; [@b38-ehp-117-17]; [@b47-ehp-117-17]; [@b102-ehp-117-17]; [@b131-ehp-117-17]).

These various review efforts and resulting publications provide transparent decision criteria for the analysis and interpretation of DNT test results, in accordance with the principles described in GD34 ([@b93-ehp-117-17]). Additionally, they demonstrate test method reliability, reproducibility, and relevance, which is attributable in part to the high level of standardization of the test methods that are recommended in the test guideline.

Future Activities
=================

Although the overall performance of the DNT test method and its ability to detect effects of concern from a regulatory perspective have been well established, the recent increase in the number of regulatory DNT studies being conducted has refocused attention on this test method. Although some argue that specific tests are insensitive (e.g., assessment of cognitive and sensory dysfunction), others suggest that the tests are overly sensitive and have a high rate of false positives ([@b135-ehp-117-17]; [@b20-ehp-117-17], [@b21-ehp-117-17]; [@b25-ehp-117-17]; [@b141-ehp-117-17]). Diverse groups have advocated increased testing for DNT ([@b7-ehp-117-17]; [@b46-ehp-117-17]; [@b82-ehp-117-17], [@b83-ehp-117-17]; [@b77-ehp-117-17]; [@b98-ehp-117-17]; [@b120-ehp-117-17]; [@b145-ehp-117-17]). There have also been calls to include evaluations of end points not currently assessed, such as social behavior ([@b25-ehp-117-17]), pharmacokinetics and neurochemistry ([@b7-ehp-117-17]; [@b32-ehp-117-17]), and changes during senescence ([@b25-ehp-117-17]). In addition, there have been criticisms of the complexity of the study, accompanied by calls for deleting some test components from the protocol ([@b60-ehp-117-17]) or using screening approaches that incorporate DNT testing into other testing protocols ([@b24-ehp-117-17]; [@b57-ehp-117-17]). Critics also claim that variability of some end points (e.g., motor activity, morphometrics) is too great to be useful ([@b18-ehp-117-17]; [@b80-ehp-117-17]; [@b148-ehp-117-17]) and that this *in vivo* test is not necessary to detect DNT ([@b8-ehp-117-17]). These diverse opinions do not invalidate the DNT study but rather highlight the need for ongoing scientifically based evaluation of this test method and the incorporation of appropriate revisions as scientific knowledge advances and as experience with the DNT study warrants.

A number of efforts are currently under way to review data from existing DNT studies, identify ways to refine the DNT test, and, if possible, reduce the number of animals used. It has been proposed that a reduction in animal use can be achieved by applying certain statistical approaches to the behavioral analysis ([@b19-ehp-117-17]; [@b101-ehp-117-17]). Reviews of historical and positive control data have demonstrated the need for more standardized reporting requirements ([@b28-ehp-117-17], [@b26-ehp-117-17]). Further retrospective reviews of control data have identified differences among laboratories in data quality and variability, suggesting methods to decrease variability ([@b27-ehp-117-17], [@b28-ehp-117-17]; [@b106-ehp-117-17], [@b103-ehp-117-17]; [@b114-ehp-117-17]). Conversely, a review of various neuropathology assessments (e.g., brain weight, standard histopathology, and morphometric assessments) identified low variability for these measures ([@b29-ehp-117-17]), concluding that no one postmortem measure is more sensitive, with each providing important data ([@b105-ehp-117-17]). The outcome of this continuing effort will allow better data interpretation, help refine requirements for future testing, and guide new methods development.

In addition to the goal of refinement of the current approach to DNT testing, there is another and more pressing driver of change in the science arena of DNT. Currently, thousands of chemicals lack even simple, basic toxicologic data (e.g., high-production-volume chemicals, pesticide inert ingredients, antimicrobial pesticides) but have a high potential for human exposure ([@b81-ehp-117-17]). Assessing potential neurotoxicologic effects for these chemicals is a major challenge confronting the chemical industry, international and national regulatory agencies, and associated stakeholders ([@b31-ehp-117-17]; [@b52-ehp-117-17]; [@b85-ehp-117-17]). New tools and methods are required to move toward a more sustainable risk assessment paradigm for these types of chemicals. Although the current DNT guidelines generate useful data for risk assessment purposes, this *in vivo* test is costly and time-consuming and uses a relatively large number of naive animals when conducted as a stand-alone study (compared with incorporating the DNT testing into other protocols, e.g., as proposed in [@b24-ehp-117-17] and [@b140-ehp-117-17]). A pressing goal of future research is to develop a validated true first-tier screening paradigm (e.g., a high-throughput *in vitro* screening battery) that can rapidly screen large numbers of chemicals for their potential to cause DNT ([@b22-ehp-117-17]; [@b58-ehp-117-17]; [@b85-ehp-117-17]; [@b141-ehp-117-17]). Coupled with development of decision frameworks (e.g., [@b23-ehp-117-17]), data from these high-throughput screens may facilitate prioritization of any further testing *in vivo*, for example, as for substances identified as potentially hazardous under the European regulation on Registration, Evaluation, Authorisation, and Restriction of Chemical Substances (REACH) ([@b37-ehp-117-17]). Data generated by the current DNT test method will be vital in the validation of these high-throughput *in vitro* methods, providing information on their utility and limits, as well as guidance on the potential use of data from these alternative methods in a risk assessment context.

Conclusions
===========

The OECD DNT TG 426 ([@b95-ehp-117-17]) represents the best available science for assessing the potential for DNT in human health risk assessment, and data generated by DNT studies are relevant and reliable for this assessment. The test methods used in the DNT have been subjected to an extensive history of international validation, peer review, and evaluation that is contained in the public record. The reproducibility, reliability, and sensitivity of these methods have been demonstrated, using a wide variety of test substances. Multiple, independent, expert scientific peer reviews affirm these conclusions, as described in this document. The OECD DNT TG 426 provides an outline of behavioral domains and morphologic end points, relevant to human neurodevelopment, that should be examined to assess potential DNT of a test compound. The results from DNT studies are used for hazard/risk assessment purposes, and in cases where data from a DNT study are not available, additional uncertainty factors may be employed by regulators to address the need for DNT data from a regulatory standpoint. This document shows that a variety of chemicals have been tested for DNT, constituting a sampled spectrum of the chemical universe that the test is proposed to investigate. Several published reports outlined herein show that the DNT study is robust and can be conducted in multiple laboratories with consistent performance.

The views expressed in this document are those of the authors and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency.

###### 

Historical contributions to the DNT guideline.

  Date           Event                                                      Summary                                                                                                                                                                                                               References
  -------------- ---------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------
  1960s--1980s   Published research on DNT and behavioral testing           Evidence that developmental exposure to chemicals and drugs can alter behavioral function in young and adult animals                                                                                                  [@b50-ehp-117-17], [@b118-ehp-117-17], [@b9-ehp-117-17], [@b14-ehp-117-17], [@b16-ehp-117-17], [@b146-ehp-117-17], [@b15-ehp-117-17], [@b1-ehp-117-17]
  1978--1984     CBTS                                                       Study to examine intra- and interlaboratory reliability and sensitivity of behavioral test methods                                                                                                                    [@b11-ehp-117-17], [@b53-ehp-117-17], [@b54-ehp-117-17]
  1984           Cincinnati Test Protocol                                   Within-laboratory comparison of CBTS test protocol with the Cincinnati Test Protocol                                                                                                                                  [@b142-ehp-117-17], [@b143-ehp-117-17], [@b144-ehp-117-17]
  1982--1985     Collaborative studies of the Japanese Teratology Society   Interlaboratory methods evaluations and assessment of six reference chemicals                                                                                                                                         [@b125-ehp-117-17], [@b126-ehp-117-17]
  1985--1988     European Interlaboratory Collaborative Study               Interlaboratory study to assess sensitivity of behavioral test procedures to detect neurotoxicity of methylmercury                                                                                                    [@b34-ehp-117-17], [@b36-ehp-117-17], [@b121-ehp-117-17]
  1989           Williamsburg Workshop                                      Workshop to evaluate the qualitative and quantitative comparability of animal and human data for DNT                                                                                                                  [@b40-ehp-117-17], [@b55-ehp-117-17]
  1993--1997     Collaborative studies of the Japanese Teratology Society   Three interlaboratory studies using behavioral teratogens comparability a core battery of tests                                                                                                                       [@b123-ehp-117-17], [@b122-ehp-117-17], [@b41-ehp-117-17], [@b79-ehp-117-17]
  1995           IPCS                                                       Interlaboratory study using neurotoxic chemicals to evaluate test validity, reliability, and measurement variability                                                                                                  [@b17-ehp-117-17], [@b62-ehp-117-17], [@b128-ehp-117-17]
  2000           ILSI workshop on DNT testing                               Workshop to review U.S. EPA DNT behavioral test methods, pharmacokinetics, and neuropathology                                                                                                                         [@b25-ehp-117-17], [@b32-ehp-117-17], [@b43-ehp-117-17], [@b67-ehp-117-17]
  2003           Japanese Interlaboratory Study                             Interlaboratory study using neurotoxic chemicals to determine sensitivity of behavioral measures                                                                                                                      [@b99-ehp-117-17]
  2003           Behavioral Test Methods Workshop                           Expert workshop to address design, conduct, and analysis of behavioral tests for neurotoxicity evaluation                                                                                                             [@b115-ehp-117-17]
  2004--2008     ILSI RSI Working Group                                     Working group focused on variability, statistical analyses, positive controls, identification and analyses, interpretation of treatment-related effects, and application of DNT testing to public health protection   [@b38-ehp-117-17], [@b26-ehp-117-17], [@b47-ehp-117-17][@b102-ehp-117-17],[@b131-ehp-117-17]

###### 

History of the DNT guideline.

  Date   Event                                                                                                                                                   Reference
  ------ ------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------
  1986   U.S. EPA OPPTS published first draft DNT protocol for peer review and public comment                                                                    [@b133-ehp-117-17]
  1991   U.S. EPA OPPTS published final DNT guideline (§83--6)                                                                                                   [@b134-ehp-117-17]
  1995   OECD Working Group on Reproduction and Developmental Toxicity (Copenhagen) recommended development of OECD Developmental Neurotoxicity Test Guideline   [@b87-ehp-117-17]
  1996   OECD expert consultation meeting (Copenhagen) provided recommendations for design of Draft OECD 426                                                     [@b88-ehp-117-17]
  1998   U.S. EPA OPPTS issued minor revisions and harmonization of DNT guideline (OPPTS 870.6300)                                                               [@b136-ehp-117-17]
  1998   Draft TG 426 submitted to National Coordinators for expert review and comment                                                                           
  2000   OECD expert consultation meeting (Washington) held to review technical issues                                                                           [@b92-ehp-117-17]
  2003   Draft TG 426 submitted to National Coordinators for expert review and comment                                                                           
  2005   OECD expert consultation meeting (Tokyo) convened to respond to remaining comments on Draft TG 426                                                      [@b94-ehp-117-17]
  2007   OECD TG 426 approved by WNT; guideline finalized                                                                                                        [@b95-ehp-117-17]

WNT, the working group of the National Coordinators of the Test Guidelines Programme.

###### 

Number of chemicals studied using the U.S. EPA DNT guideline or draft OECD DNT guideline.

  Chemical class                                                   No. of studies
  ---------------------------------------------------------------- ----------------
  Industrial chemicals                                             8
  Miscellaneous agents[a](#tfn2-ehp-117-17){ref-type="table-fn"}   4
  Pharmaceuticals                                                  3
  Pesticides                                                       73
  Positive control chemicals                                       15
  Solvents                                                         7

Food additives, cigarette smoke, dietary restriction, and maternal separation.

###### 

Examples of chemicals and other stressors tested using the U.S. EPA DNT guideline or OECD TG 426.[a](#tfn3-ehp-117-17){ref-type="table-fn"}

  ----------------------------------------- -------------------------------- -------------------------------------
  Abamectin                                 Dichlorvos (2)                   Methyl parathion
  Acephate                                  Dicrotophos                      Methylazoxymethanol (2)
  Acetamiprid                               Dietary restriction              Methylmercury
  Acibenzolar-*s*-methyl                    Dimethoate                       *n*-Methylneodecanamide
  Acrylamide                                Disulfoton                       Molinate
  AE-0172747                                Emamectin                        Naled
  Aldicarb                                  Epidermal growth factor          Nelfinavir
  Alitame                                   *s*-Ethyldipropylthiocarbamate   Nitrous oxide
  Amicarbazone                              Ethoprophos                      Octamethylcyclotetrasiloxane
  Atorvastatin                              Ethylbenzene                     Perchlorate
  Azinphos methyl                           Etofenprox                       Phorate (2)
  BAS 510F                                  Fenamidone                       Prochloraz
  BAS 670H                                  Fenamiphos                       Profenofos
  Bifenthrin                                Fentin hydroxide                 Propylthiouracil (2)
  Carbaryl                                  Fipronil                         Pymetrozine
  Carbofuran                                Flubendiamide                    Pyrasulfotole
  Chlorfenapyr                              Flufenacet                       Spirodiclofen
  Chlorite, sodium                          Glufosinate ammonium             Prothioconazole
  Chlorpyrifos                              Glyphosate trimesium             Styrene
  CI-943                                    GN1180 (MN rgp120/HIV-1)         Tetrabromobisphenol A
  Cigarette smoke                           Hydrogen sulfide                 Tebuconazole
  Clodinafop propargyl                      Imidacloprid                     Terbufos
  Clothianidin                              Iminodiproprionitrile            Tetrachlorvinphos
  Coumaphos                                 Indoxacarb                       Thiamethoxam
  Cyclohexanemethanol                       Isopropanol                      Thiocloprid
  λ-Cyhalothrin                             Isoxaflutole                     Thiram
  β-Cyfluthrin                              Lead nitrate                     Triallate
  Cymoxanil                                 Lindane                          Tribufos
  ϑ-Cypermethrin                            Malathion                        Trichlorfon
  Decamethylcyclopentasiloxane              Maternal separation              1,1,1-Trichloroethane
  *p,p*-DDT                                 Methamidaphos                    Trichloroethylene
  DEET (*N*,*N*-diethyl-*meta*-toluamide)   *p*-Methane-3,8-diol             Triethylene glycol monomethyl ether
  Deltamethrin                              Methimazole (6)                  Trimethyltin
  Diazepam                                  Methyl bromide                   Ziram
  Diazinon                                                                   
  ----------------------------------------- -------------------------------- -------------------------------------

Numbers indicate the number of studies conducted for that chemical
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